Diffuse large B-cell non-Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引：46
|
作者：
Tilly, H. [1 ]
Dreyling, M. [2 ]
机构：
[1] Ctr Henri Becquerel, Dept Hematol, F-76038 Rouen, France
[2] Univ Hosp Grosshadern, LMU Munich, Dept Med 3, Munich, Germany
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
CHEMOTHERAPY PLUS RITUXIMAB; RANDOMIZED CONTROLLED-TRIAL; HIGH-DOSE THERAPY; ELDERLY-PATIENTS; TRANSPLANTATION; CHOP; RADIOTHERAPY; PROGNOSIS; ICE;
D O I：
10.1093/annonc/mdq203
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：v172 / v174
页数：3
相关论文
共 50 条
  • [21] Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Glynne-Jones, R.
    Northover, J. M. A.
    Cervantes, A.
    ANNALS OF ONCOLOGY, 2010, 21 : v87 - v92
  • [22] Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Vogel, A.
    Cervantes, A.
    Chau, I.
    Daniele, B.
    Llovet, J.
    Meyer, T.
    Nault, J. -C.
    Neumann, U.
    Ricke, J.
    Sangro, B.
    Schirmacher, P.
    Verslype, C.
    Zech, C. J.
    Arnold, D.
    Martinelli, E.
    ANNALS OF ONCOLOGY, 2018, 29 : 238 - 255
  • [23] Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Haie-Meder, C.
    Morice, P.
    Castiglione, M.
    ANNALS OF ONCOLOGY, 2010, 21 : v37 - v40
  • [24] Lymphopenia predicts preclinical relapse in the routine follow-up of patients with diffuse large B-cell lymphoma
    Wei, Xiaolei
    Wei, Yongqiang
    Huang, Fen
    Jing, Hui
    Xie, Muchen
    Hao, Xiaoxiao
    Feng, Ru
    LEUKEMIA & LYMPHOMA, 2015, 56 (05) : 1261 - 1265
  • [25] Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    D'Addario, G.
    Frueh, M.
    Reck, M.
    Baumann, P.
    Klepetko, W.
    Felip, E.
    ANNALS OF ONCOLOGY, 2010, 21 : v116 - v119
  • [26] Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines tor diagnosis, treatment and follow-up
    Dreyling, M.
    Ghielmini, M.
    Rule, S.
    Salles, G.
    Ladetto, M.
    Tonino, S. H.
    Herfarth, K.
    Seymour, J. F.
    Jerkeman, M.
    ANNALS OF ONCOLOGY, 2021, 32 (03) : 298 - 308
  • [27] BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma
    Palickova, Monika
    Mocikova, Heidi
    Vernerova, Zdenka
    Campr, Vit
    Kozak, Tomas
    LEUKEMIA & LYMPHOMA, 2013, 54 (09) : 2081 - 2082
  • [28] Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Zucca, E.
    Arcaini, L.
    Buske, C.
    Johnson, P. W.
    Ponzoni, M.
    Raderer, M.
    Ricardi, U.
    Salar, A.
    Stamatopoulos, K.
    Thieblemont, C.
    Wotherspoon, A.
    Ladetto, M.
    ANNALS OF ONCOLOGY, 2020, 31 (01) : 17 - 29
  • [29] Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Stahel, R. A.
    Weder, W.
    Lievens, Y.
    Felip, E.
    ANNALS OF ONCOLOGY, 2010, 21 : v126 - v128
  • [30] Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Baudin, E.
    Caplin, M.
    Garcia-Carbonero, R.
    Fazio, N.
    Ferolla, P.
    Filosso, P. L.
    Frilling, A.
    de Herder, W. W.
    Hoersch, D.
    Knigge, U.
    Korse, C. M.
    Lim, E.
    Lombard-Bohas, C.
    Pavel, M.
    Scoazec, J. Y.
    Sundin, A.
    Berruti, A.
    ANNALS OF ONCOLOGY, 2021, 32 (04) : 439 - 451
12345